We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Celator Pharmaceuticals Inc. (MM) | NASDAQ:CPXX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 30.24 | 29.96 | 30.29 | 0 | 01:00:00 |
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)
☐
(b) ☐ |
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER
0
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
1
|
NAMES OF REPORTING PERSONS
Garden State Life Sciences Venture Fund, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)
☐
(b) ☐ |
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER
0
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures Capital, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)
☐
(b) ☐ |
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER
0
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures Capital, LLC
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a)
☐
(b) ☐ |
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER
0
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
0
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
☐
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
Item 1(a)
|
Name of Issuer:
Celator Pharmaceuticals, Inc.
|
Item 1(b)
|
Address of Issuer's Principal Executive Offices:
200 Princeton South Corporate Drive, Suite 180
Ewing, NJ 08628 |
Item 2(a)
|
Name of Person Filing:
Quaker BioVentures, L.P.
Garden State Life Sciences Venture Fund, L.P.
Quaker BioVentures Capital, L.P.
Quaker BioVentures Capital, LLC
|
Item 2(b)
|
Address of Principal Business Office or, if none, Residence:
The address of the principal business office of each of the Reporting Persons is 2929 Arch Street, Cira Centre, Philadelphia, PA 19104-2868.
|
Item 2(c)
|
Citizenship:
Quaker BioVentures, L.P. – Delaware
Garden State Life Sciences Venture Fund, L.P. – Delaware
Quaker BioVentures Capital, L.P. – Delaware
Quaker BioVentures Capital, LLC – Delaware
|
Item 2(d)
|
Title of Class of Securities:
Common Stock, $0.001 par value per share
|
Item 2(e)
|
CUSIP Number:
15089R102
|
Item 3
|
Not applicable.
|
Item 4
|
Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a)
Amount beneficially owned:
Quaker BioVentures, L.P. – 0
Garden State Life Sciences Venture Fund, L.P. – 0
Quaker BioVentures Capital, L.P. – 0
Quaker BioVentures Capital, LLC – 0
(b)
Percent of class:
Quaker BioVentures, L.P. – 0%
Garden State Life Sciences Venture Fund, L.P. – 0%
Quaker BioVentures Capital, L.P. – 0%
Quaker BioVentures Capital, LLC – 0%
(c)
Number of shares as to which the person has:
(i)
Sole power to vote or to direct the vote
Quaker BioVentures, L.P. – 0
Garden State Life Sciences Venture Fund, L.P. – 0
Quaker BioVentures Capital, L.P. – 0
Quaker BioVentures Capital, LLC – 0
(ii)
Shared power to vote or to direct the vote
Quaker BioVentures, L.P. – 0
Garden State Life Sciences Venture Fund, L.P. – 0
Quaker BioVentures Capital, L.P. – 0
Quaker BioVentures Capital, LLC – 0
(iii)
Sole power to dispose or to direct the disposition of
Quaker BioVentures, L.P. – 0
Garden State Life Sciences Venture Fund, L.P. – 0
Quaker BioVentures Capital, L.P. – 0
Quaker BioVentures Capital, LLC – 0
(iv)
Shared power to dispose or to direct the disposition of
Quaker BioVentures, L.P. – 0
Garden State Life Sciences Venture Fund, L.P. – 0
Quaker BioVentures Capital, L.P. – 0
Quaker BioVentures Capital, LLC – 0
|
Item 5
|
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following
☒
.
|
Item 6
|
Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
|
Item 7
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not applicable.
|
Item 8
|
Identification and Classification of Members of the Group.
Each of the Reporting Persons may be deemed to be a member of a group with respect to the issuer or securities of the issuer for the purpose of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended.
|
Item 9
|
Notice of Dissolution of Group.
Not applicable.
|
Item 10
|
Certification.
Not applicable.
|
Date: February 14, 2017
|
QUAKER BIOVENTURES, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name:
Richard S. Kollender
Title:
Executive Manager
|
GARDEN STATE LIFE SCIENCES VENTURE FUND, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name:
Richard S. Kollender
Title:
Executive Manager
|
|
QUAKER BIOVENTURES CAPITAL, L.P.
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name:
Richard S. Kollender
Title:
Executive Manager
|
|
QUAKER BIOVENTURES CAPITAL, LLC
/s/ Richard S. Kollender
Name:
Richard S. Kollender
Title:
Executive Manager
|
Date: February 14, 2017
|
QUAKER BIOVENTURES, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name:
Richard S. Kollender
Title:
Executive Manager
|
GARDEN STATE LIFE SCIENCES VENTURE FUND, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name:
Richard S. Kollender
Title:
Executive Manager
|
|
QUAKER BIOVENTURES CAPITAL, L.P.
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name:
Richard S. Kollender
Title:
Executive Manager
|
|
QUAKER BIOVENTURES CAPITAL, LLC
/
s/ Richard S. Kollender
Name:
Richard S. Kollender
Title:
Executive Manager
|
1 Year Celator Pharmaceuticals Inc. Chart |
1 Month Celator Pharmaceuticals Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions